|
|
Recent Articles
-
Goldman Sachs Delivers in First Quarter
Apr 15, 2024
-
Image Source: Goldman Sachs.
Goldman Sachs put up solid first-quarter 2024 results across all lines of its business, revealing that capital markets activity remains very healthy, even in the face of elevated interest rates. Goldman Sachs' book value per share was $321.10 at the end of the first quarter, revealing that shares are trading at 1.25x book at the time of this writing.
-
Vertex Pharma to Acquire Alpine Immune Services
Apr 13, 2024
-
Image: Vertex Pharma’s shares have had a nice run the past couple years.
On April 10, Vertex Pharma announced that it had entered into an agreement where Vertex will acquire Alpine Immune Services for $65 per share or ~$4.9 billion in cash. We have no qualms with the deal for Alpine, and we expect Vertex Pharma to continue to deliver for shareholders.
-
JPMorgan Cautious on Geopolitical Tensions and Inflationary Pressures
Apr 12, 2024
-
Image Source: Hakan Dahlstrom.
On April 12, JPMorgan reported mixed first-quarter 2024 results. JPMorgan is one of our favorite banks, in part due to strong leadership at the top and solid fortress-like balance sheet. Though we don’t include any individual bank in the newsletter portfolios, we do think the Financial Select Sector SPDR makes sense for diversification reasons, as showcased in the Best Ideas Newsletter portfolio. Shares of JPMorgan yield ~2.4% at the time of this writing.
-
Dividend Increases/Decreases for the Week of April 12
Apr 12, 2024
-
Let's take a look at firms raising/lowering their dividends this week.
|
